Context

Part of Janatahack Hackathon in Analytics Vidhya

Content

The healthcare sector has long been an early adopter of and benefited greatly from technological advances. These days, machine learning plays a key role in many health-related realms, including the development of new medical procedures, the handling of patient data, health camps and records, and the treatment of chronic diseases.

MedCamp organizes health camps in several cities with low work life balance. They reach out to working people and ask them to register for these health camps. For those who attend, MedCamp provides them facility to undergo health checks or increase awareness by visiting various stalls (depending on the format of camp).

MedCamp has conducted 65 such events over a period of 4 years and they see a high drop off between “Registration” and number of people taking tests at the Camps. In last 4 years, they have stored data of ~110,000 registrations they have done.

One of the huge costs in arranging these camps is the amount of inventory you need to carry. If you carry more than required inventory, you incur unnecessarily high costs. On the other hand, if you carry less than required inventory for conducting these medical checks, people end up having bad experience.

The Process:

MedCamp employees / volunteers reach out to people and drive registrations.
During the camp, People who “ShowUp” either undergo the medical tests or visit stalls depending on the format of health camp.

Other things to note:

Since this is a completely voluntary activity for the working professionals, MedCamp usually has little profile information about these people.
For a few camps, there was hardware failure, so some information about date and time of registration is lost.
MedCamp runs 3 formats of these camps. The first and second format provides people with an instantaneous health score. The third format provides  
information about several health issues through various awareness stalls.

Favorable outcome:

For the first 2 formats, a favourable outcome is defined as getting a health_score, while in the third format it is defined as visiting at least a stall.
You need to predict the chances (probability) of having a favourable outcome.

Train / Test split:

Camps started on or before 31st March 2006 are considered in Train
Test data is for all camps conducted on or after 1st April 2006.

Acknowledgements

Credits to AV

Inspiration

To share with the data science community to jump start their journey in Healthcare Analytics

📌**Context**

The Healthcare Workforce Mental Health Dataset is designed to explore workplace mental health challenges in the healthcare industry, an environment known for high stress and burnout rates.

This dataset enables users to analyze key trends related to:

💠 Workplace Stressors: Examining the impact of heavy workloads, poor work environments, and emotional demands.

💠 Mental Health Outcomes: Understanding how stress and burnout influence job satisfaction, absenteeism, and turnover intention.

💠 Educational & Analytical Applications: A valuable resource for data analysts, students, and career changers looking to practice skills in data exploration and data visualization.

To help users gain deeper insights, this dataset is fully compatible with a Power BI Dashboard, available as part of a complete analytics bundle for enhanced visualization and reporting.

📌**Source**

This dataset was synthetically generated using the following methods:

💠 Python & Data Science Techniques: Probabilistic modeling to simulate realistic data distributions. Industry-informed variable relationships based on healthcare workforce studies.

💠 Guidance & Validation Using AI (ChatGPT): Assisted in refining dataset realism and logical mappings.

💠 Industry Research & Reports: Based on insights from WHO, CDC, OSHA, and academic studies on workplace stress and mental health in healthcare settings.

📌**Inspiration**

This dataset was inspired by ongoing discussions in healthcare regarding burnout, mental health, and staff retention. The goal is to bridge the gap between raw data and actionable insights by providing a structured, analyst-friendly dataset.

For those who want a ready-to-use reporting solution, a Power BI Dashboard Template is available, designed for interactive data exploration, workforce insights, and stress factor analysis.

📌**Important Note** This dataset is synthetic and intended for educational purposes only. It is not real-world employee data and should not be used for actual decision-making or policy implementation.

The global healthcare industry is huge, and growing everyday. BoldData provides a customized file with all 2.509.454 Healthcare companies of the highest quality. From doctors, physicians to hospitals and nursing homes.

The global healthcare industry is set to grow by 4.82% during 2018, while the pharmaceuticals market saw growth of 5.8% in 2017. We can select your perfect Healthcare companies list on a large number of characteristics: from region to turnover, sector and the number of employees. Discover some of the options in the overview below and request a free quote via the contact form. Are you looking for a different industry region, city or country? No problem: we can help you worldwide with addresses in all industries.

Graph and download economic data for All Employees, Health Care (CES6562000101) from Jan 1990 to Jun 2025 about health, establishment survey, education, services, employment, and USA.

Between January and September 2024, healthcare organizations in the United States saw 491 large-scale data breaches, resulting in the loss of over 500 records. This figure has increased significantly in the last decade. To date, the highest number of large-scale data breaches in the U.S. healthcare sector was recorded in 2023, with a reported 745 cases.

Big Data Analytics in Healthcare Market Outlook

The global market size for Big Data Analytics in Healthcare was valued at approximately USD 34 billion in 2023 and is anticipated to grow at a robust CAGR of 11.9%, reaching an estimated USD 90 billion by 2032. This remarkable growth is driven by the increasing adoption of data-driven decision-making processes within the healthcare sector, spurred by the mounting pressure to enhance operational efficiencies, improve patient outcomes, and reduce overall healthcare costs. The integration of big data analytics within healthcare systems is enabling organizations to leverage vast amounts of data, leading to enhanced patient care and streamlined operations.

A significant growth factor fueling the expansion of the big data analytics market in healthcare is the ever-increasing volume of data generated by healthcare systems. With the surge of electronic health records, wearable health devices, and various other digital health technologies, the volume of data being generated is unprecedented. This data, if analyzed correctly, holds the potential to transform healthcare delivery models, allowing for more precise diagnostics, personalized treatment plans, and proactive disease management strategies. Consequently, healthcare organizations are increasingly investing in big data analytics tools to harness this data for clinical and operational improvements.

Another key driver of market growth is the growing emphasis on value-based care and the need for healthcare providers to demonstrate high-quality patient outcomes. Value-based care models require providers to focus on the quality rather than the quantity of care delivered, inherently demanding the use of advanced analytics to derive actionable insights from patient data. Big data analytics facilitates the identification of patterns and trends that can lead to improved treatment effectiveness and patient satisfaction. This shift in care models is prompting healthcare organizations to integrate sophisticated analytics solutions that help in predictive modeling, trend analysis, and real-time decision-making, further propelling market expansion.

Additionally, the increasing incidence of chronic diseases worldwide is driving the need for more efficient healthcare services. Big data analytics in healthcare can play a critical role in managing chronic diseases by enabling preventive care and personalized treatment plans. By analyzing patient data, including historical health records, genetic information, and lifestyle choices, healthcare providers can predict potential health issues and intervene early, thereby improving patient outcomes and reducing healthcare costs. This capability is essential in managing the global burden of chronic diseases, thereby boosting the adoption of big data analytics solutions in the healthcare sector.

Regionally, North America dominates the market due to the presence of advanced healthcare infrastructure, the availability of technologically advanced products, and the high adoption rate of healthcare IT solutions. The region's robust regulatory environment and substantial investments in healthcare IT make it a fertile ground for the growth of big data analytics solutions. However, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by increasing government initiatives supporting the digitization of healthcare, burgeoning healthcare infrastructure, and a growing focus on precision medicine. The integration of big data analytics in healthcare across diverse regions is indicative of its global importance in optimizing healthcare delivery and patient care.

Component Analysis

In the realm of big data analytics in healthcare, the component segment is vitally instrumental to the market's evolution and includes software and services. Software solutions are the backbone of big data analytics, providing healthcare organizations with the necessary tools to collect, process, and analyze vast datasets. These solutions encompass data management and analytical platforms, which are indispensable for extracting actionable insights from disparate data sources. The software component is continually evolving with advancements in artificial intelligence and machine learning, which enhance data analytics capabilities. Moreover, the increasing demand for user-friendly, customizable software solutions is driving innovation and growth within this segment.

The services component, on the other hand, plays a critical role in the implementation and maintenance of big data analytics solutions. This component includes cons

The amount of global healthcare data is expected to increase dramatically by the year 2020. Early estimates from 2013 suggest that there were about 153 exabytes of healthcare data generated in that year. However, projections indicate that there could be as much as 2,314 exabytes of new data generated in 2020.

Success.ai’s Healthcare Industry Leads Data empowers businesses and organizations to connect with key decision-makers and stakeholders in the global healthcare and pharmaceutical sectors. Leveraging over 170 million verified professional profiles and 30 million company profiles, this dataset includes detailed contact information, firmographic insights, and leadership data for hospitals, clinics, biotech firms, medical device manufacturers, pharmaceuticals, and other healthcare-related enterprises. Whether your goal is to pitch a new medical technology, partner with healthcare providers, or conduct market research, Success.ai ensures that your outreach and strategic planning are guided by reliable, continuously updated, and AI-validated data.

Why Choose Success.ai’s Healthcare Industry Leads Data?

1. Comprehensive Contact Information

   • Access verified work emails, phone numbers, and LinkedIn profiles of healthcare administrators, pharmaceutical executives, R&D directors, procurement officers, and medical staff.
   • AI-driven validation ensures 99% accuracy, reducing wasted efforts and fostering efficient communication.

2. Global Reach Across Healthcare Segments

   • Includes profiles from hospitals, private clinics, pharmaceutical companies, biotech startups, research institutions, and medical supply chain partners.
   • Covers North America, Europe, Asia-Pacific, South America, and the Middle East, enabling a global perspective on healthcare systems and opportunities.

3. Continuously Updated Datasets

   • Real-time updates reflect leadership changes, organizational shifts, and emerging trends in patient care, medical innovation, and regulatory compliance.

4. Ethical and Compliant

   • Adheres to GDPR, CCPA, and other global data privacy regulations, ensuring your data usage respects legal standards and patient confidentiality norms.

Data Highlights:

• 170M+ Verified Professional Profiles: Connect with healthcare and pharmaceutical professionals, decision-makers, and influencers worldwide.
• 50M Work Emails: AI-validated for direct, accurate communication and reduced bounce rates.
• 30M Company Profiles: Gain insights into organizational structures, operational scales, and specialization areas.
• 700M Global Professional Profiles: Enriched datasets to support market analysis, product development, and strategic planning.

Key Features of the Dataset:

1. Healthcare Decision-Maker Profiles

   • Identify and engage with CEOs, CIOs, CFOs, chief medical officers, hospital administrators, clinical directors, and procurement specialists.
   • Target professionals who influence equipment purchases, medical supply chain decisions, drug trial approvals, and healthcare delivery models.

2. Detailed Business Profiles

   • Access firmographic data, including company sizes, revenue ranges, key markets, and service lines for a holistic understanding of target organizations.
   • Leverage comprehensive insights to position your products, services, or solutions as tailored fits for specific operational needs.

3. Advanced Filters for Precision Targeting

   • Filter by region, specialty (oncology, cardiology, diagnostics, etc.), hospital size, pharmaceutical focus, or research areas.
   • Align campaigns with unique healthcare demands, reimbursement models, and regulatory environments.

4. AI-Driven Enrichment

   • Profiles enriched with actionable data enable personalized messaging, highlight value propositions, and enhance engagement outcomes with healthcare stakeholders.

Strategic Use Cases:

1. Sales and Business Development

   • Present medical devices, pharma products, or healthcare IT solutions to hospital administrators, chief medical officers, and procurement managers.
   • Build relationships with decision-makers who oversee budgeting, supplier selection, and patient care initiatives.

2. Market Research and Product Innovation

   • Analyze trends in patient treatments, drug pipelines, and healthcare infrastructure to inform R&D and product roadmaps.
   • Identify emerging specialties, new treatment modalities, and growth markets to focus marketing, sales, and investment efforts.

3. Strategic Partnerships and Alliances

   • Connect with R&D directors, biotech executives, or hospital groups to explore collaborations, clinical trials, and joint ventures.
   • Foster partnerships that accelerate product development, enhance patient outcomes, and drive long-term competitiveness.

4. Recruitment and Talent Acquisition

   • Target HR professionals and department heads seeking qualified medical staff, researchers, pharmaceutical reps, and administrative personnel.
   • Offer staffing, training, or professional development services to healthcare institutions aiming to improve service delivery and compliance.

Why Choose Success.ai?

1. Best Price Guarantee
   • Access high-quality, verified data at...

Healthcare Data Storage Market size was valued at USD 3.97 Billion in 2024 and is projected to reach USD 10.27 Billion by 2032, growing at a CAGR of 13.90% during the forecast period 2026-2032.Global Healthcare Data Storage Market DriversThe market drivers for the Healthcare Data Storage Market can be influenced by various factors. These may include:Growing volume of healthcare data: The amount of data produced by healthcare providers has increased dramatically as a result of the digitalization of medical records. This covers genomic information, medical imaging, electronic health records (EHRs), and more. To handle this data, healthcare institutions need effective and safe storage options.Severe laws and compliance requirements: HIPAA (Health Insurance Portability and Accountability Act) in the US and GDPR (General Data Protection Regulation) in Europe are two examples of the severe laws that apply to healthcare data. In order to protect patient information, these requirements mandate that healthcare organisations employ secure data storage solutions.Cloud storage is becoming more and more popular since it is affordable, flexible, and scalable, which appeals to healthcare institutions. Adoption is accelerated by cloud storage companies' provision of specialised healthcare cloud solutions that meet legal and regulatory standards.Technological developments: Artificial intelligence (AI), machine learning (ML), and big data analytics are some of the technologies that are revolutionising healthcare. To handle the massive volumes of data collected and analysed, these technologies need reliable data storage systems.Growing need for data interoperability: In order to enhance patient care coordination and results, healthcare providers are placing a greater emphasis on interoperability. This calls for the smooth transfer of medical data between various systems, which calls for trustworthy data storage options.Escalating healthcare expenses: There is pressure on healthcare institutions to save expenses without sacrificing care quality. Healthcare data management and storage operations can be made more cost-effective with the use of efficient data storage solutions.Growing comprehension of data security's significance Healthcare data breaches may result in severe repercussions, such as monetary losses and reputational harm. To safeguard patient data from online dangers, healthcare institutions are investing in secure data storage solutions.

Update — December 7, 2014. – Evidence-based medicine (EBM) is not working for many reasons, for example: 1. Incorrect in their foundations (paradox): hierarchical levels of evidence are supported by opinions (i.e., lowest strength of evidence according to EBM) instead of real data collected from different types of study designs (i.e., evidence). http://dx.doi.org/10.6084/m9.figshare.1122534 2. The effect of criminal practices by pharmaceutical companies is only possible because of the complicity of others: healthcare systems, professional associations, governmental and academic institutions. Pharmaceutical companies also corrupt at the personal level, politicians and political parties are on their payroll, medical professionals seduced by different types of gifts in exchange of prescriptions (i.e., bribery) which very likely results in patients not receiving the proper treatment for their disease, many times there is no such thing: healthy persons not needing pharmacological treatments of any kind are constantly misdiagnosed and treated with unnecessary drugs. Some medical professionals are converted in K.O.L. which is only a puppet appearing on stage to spread lies to their peers, a person supposedly trained to improve the well-being of others, now deceits on behalf of pharmaceutical companies. Probably the saddest thing is that many honest doctors are being misled by these lies created by the rules of pharmaceutical marketing instead of scientific, medical, and ethical principles. Interpretation of EBM in this context was not anticipated by their creators. “The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs.” ―Peter C. Gøtzsche “doctors and their organisations should recognise that it is unethical to receive money that has been earned in part through crimes that have harmed those people whose interests doctors are expected to take care of. Many crimes would be impossible to carry out if doctors weren’t willing to participate in them.” —Peter C Gøtzsche, The BMJ, 2012, Big pharma often commits corporate crime, and this must be stopped. Pending (Colombia): Health Promoter Entities (In Spanish: EPS ―Empresas Promotoras de Salud).

1. Misinterpretations New technologies or concepts are difficult to understand in the beginning, it doesn’t matter their simplicity, we need to get used to new tools aimed to improve our professional practice. Probably the best explanation is here in these videos (credits to Antonio Villafaina for sharing these videos with me). English https://www.youtube.com/watch?v=pQHX-SjgQvQ&w=420&h=315 Spanish https://www.youtube.com/watch?v=DApozQBrlhU&w=420&h=315 ----------------------- Hypothesis: hierarchical levels of evidence based medicine are wrong Dear Editor, I have data to support the hypothesis described in the title of this letter. Before rejecting the null hypothesis I would like to ask the following open question:Could you support with data that hierarchical levels of evidence based medicine are correct? (1,2) Additional explanation to this question: – Only respond to this question attaching publicly available raw data.– Be aware that more than a question this is a challenge: I have data (i.e., evidence) which is contrary to classic (i.e., McMaster) or current (i.e., Oxford) hierarchical levels of evidence based medicine. An important part of this data (but not all) is publicly available. References
2. Ramirez, Jorge H (2014): The EBM challenge. figshare. http://dx.doi.org/10.6084/m9.figshare.1135873
3. The EBM Challenge Day 1: No Answers. Competing interests: I endorse the principles of open data in human biomedical research Read this letter on The BMJ – August 13, 2014.http://www.bmj.com/content/348/bmj.g3725/rr/762595Re: Greenhalgh T, et al. Evidence based medicine: a movement in crisis? BMJ 2014; 348: g3725. _ Fileset contents Raw data: Excel archive: Raw data, interactive figures, and PubMed search terms. Google Spreadsheet is also available (URL below the article description). Figure 1. Unadjusted (Fig 1A) and adjusted (Fig 1B) PubMed publication trends (01/01/1992 to 30/06/2014). Figure 2. Adjusted PubMed publication trends (07/01/2008 to 29/06/2014) Figure 3. Google search trends: Jan 2004 to Jun 2014 / 1-week periods. Figure 4. PubMed publication trends (1962-2013) systematic reviews and meta-analysis, clinical trials, and observational studies.
   Figure 5. Ramirez, Jorge H (2014): Infographics: Unpublished US phase 3 clinical trials (2002-2014) completed before Jan 2011 = 50.8%. figshare.http://dx.doi.org/10.6084/m9.figshare.1121675 Raw data: "13377 studies found for: Completed | Interventional Studies | Phase 3 | received from 01/01/2002 to 01/01/2014 | Worldwide". This database complies with the terms and conditions of ClinicalTrials.gov: http://clinicaltrials.gov/ct2/about-site/terms-conditions Supplementary Figures (S1-S6). PubMed publication delay in the indexation processes does not explain the descending trends in the scientific output of evidence-based medicine. Acknowledgments I would like to acknowledge the following persons for providing valuable concepts in data visualization and infographics:
4. Maria Fernanda Ramírez. Professor of graphic design. Universidad del Valle. Cali, Colombia.
5. Lorena Franco. Graphic design student. Universidad del Valle. Cali, Colombia. Related articles by this author (Jorge H. Ramírez)
6. Ramirez JH. Lack of transparency in clinical trials: a call for action. Colomb Med (Cali) 2013;44(4):243-6. URL: http://www.ncbi.nlm.nih.gov/pubmed/24892242
7. Ramirez JH. Re: Evidence based medicine is broken (17 June 2014). http://www.bmj.com/node/759181
8. Ramirez JH. Re: Global rules for global health: why we need an independent, impartial WHO (19 June 2014). http://www.bmj.com/node/759151
9. Ramirez JH. PubMed publication trends (1992 to 2014): evidence based medicine and clinical practice guidelines (04 July 2014). http://www.bmj.com/content/348/bmj.g3725/rr/759895 Recommended articles
10. Greenhalgh Trisha, Howick Jeremy,Maskrey Neal. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725
11. Spence Des. Evidence based medicine is broken BMJ 2014; 348:g22
12. Schünemann Holger J, Oxman Andrew D,Brozek Jan, Glasziou Paul, JaeschkeRoman, Vist Gunn E et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 2008; 336:1106
13. Lau Joseph, Ioannidis John P A, TerrinNorma, Schmid Christopher H, OlkinIngram. The case of the misleading funnel plot BMJ 2006; 333:597
14. Moynihan R, Henry D, Moons KGM (2014) Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much. PLoS Med 11(7): e1001655. doi:10.1371/journal.pmed.1001655
15. Katz D. A-holistic view of evidence based medicinehttp://thehealthcareblog.com/blog/2014/05/02/a-holistic-view-of-evidence-based-medicine/ ---

Big Data in Healthcare Market Outlook

According to our latest research, the global Big Data in Healthcare market size reached USD 41.2 billion in 2024, demonstrating robust expansion driven by the increasing adoption of advanced analytics and data-driven decision-making in the healthcare sector. The market is projected to grow at a CAGR of 17.4% from 2025 to 2033, reaching an estimated value of USD 154.1 billion by 2033. This significant growth is primarily attributed to the surging volume of healthcare data, advancements in artificial intelligence and machine learning, and the increasing focus on improving patient outcomes and operational efficiency across healthcare institutions worldwide.

One of the primary growth factors fueling the Big Data in Healthcare market is the exponential rise in healthcare data generation, driven by the widespread adoption of electronic health records (EHRs), wearable devices, and connected medical equipment. As healthcare organizations seek to harness actionable insights from this data deluge, the demand for advanced analytics solutions has surged. The integration of big data analytics enables providers to enhance clinical decision-making, reduce medical errors, and optimize treatment protocols, thereby improving patient care and safety. Furthermore, the growing emphasis on value-based care models has compelled healthcare stakeholders to invest in robust data analytics platforms that can support population health management and evidence-based medicine, further accelerating market expansion.

Another key driver of the Big Data in Healthcare market is the growing need for cost containment and operational efficiency within healthcare organizations. Rising healthcare costs, resource constraints, and the increasing complexity of healthcare delivery have prompted providers and payers to leverage big data analytics to streamline operations, reduce redundancies, and enhance resource allocation. Financial analytics applications, in particular, are witnessing substantial uptake as organizations strive to identify cost-saving opportunities, detect fraudulent claims, and improve revenue cycle management. Additionally, operational analytics solutions are being deployed to optimize supply chain management, workforce planning, and facility utilization, resulting in enhanced productivity and reduced overheads.

The rapid advancement of artificial intelligence (AI), machine learning, and cloud computing technologies has also played a pivotal role in propelling the Big Data in Healthcare market forward. AI-driven analytics platforms are enabling healthcare providers to uncover hidden patterns in patient data, predict disease outbreaks, and personalize treatment plans based on individual patient profiles. The proliferation of cloud-based solutions has further democratized access to advanced analytics tools, allowing even small and medium-sized healthcare organizations to leverage big data capabilities without significant upfront investments in IT infrastructure. This technological evolution is expected to continue driving innovation and adoption across the global healthcare landscape.

From a regional perspective, North America continues to dominate the Big Data in Healthcare market, accounting for the largest revenue share in 2024, followed by Europe and Asia Pacific. The region's leadership is underpinned by robust healthcare IT infrastructure, high adoption rates of electronic health records, and strong government initiatives promoting data interoperability and healthcare digitization. Meanwhile, Asia Pacific is poised for the fastest growth during the forecast period, fueled by rapid healthcare modernization, expanding digital health initiatives, and increasing investments in healthcare analytics by both public and private sectors. As healthcare systems worldwide continue to prioritize data-driven transformation, the market's regional landscape is expected to evolve, with emerging economies playing an increasingly prominent role in shaping future growth trajectories.

According to Cognitive Market Research, the global big data analytics in healthcare market size is USD 30251.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 17.20% from 2024 to 2031.

North America held the major market of more than 40% of the global revenue with a market size of USD 12100.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 9075.36 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 6957.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2031.
Latin America's market has more than 5% of the global revenue, with a market size of USD 16.6 million in 2024, and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 605.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.9% from 2024 to 2031.
The hospitals & clinics category held the highest big data analytics in healthcare market revenue share in 2024.

Market Dynamics of Big Data Analytics in Healthcare Market

Key Drivers for Big Data Analytics in Healthcare Market

Growing Use of EMR and EHR to Increase the Demand Globally:

One aspect that has contributed to the widespread implementation of EHR is government backing for their adoption, given their advantages over traditional paper-based health records. Adoption of EHRs benefits ambulatory practices and patients alike because they enhance patient care, facilitate faster access to records, and improve care coordination; increase practice efficiency and reduce costs through reduced paperwork; foster patient participation and transparency; and improve diagnostic and patient outcomes through accurate prescribing. For instance, To safeguard and legitimize digital healthcare data, the Indian government introduced the Digital Information Security in Healthcare Act (DISHA) in March 2019. The purpose of DISHA is to control the creation, gathering, storing, processing, sharing, and ownership of individually identifiable health information and patient health data. (Source: https://www.znetlive.com/blog/digital-information-security-healthcare-act-disha/).

Growing Need to Lower Medical Expenses to Propel Market Growth:

These days, rising operating costs are a problem for many hospitals and health organizations. Medical practices can operate more efficiently thanks to healthcare analytics. Reduced transcribing expenses, less time spent on paperwork, better billing documentation, fewer or no chart pulls, and storage, and better patient outcomes and care can all help cut down on operating expenses. It is said that putting this into practice saves a lot of money. Moreover, hospitals and medical practitioners can reduce unnecessary and excessive spending by utilizing analytical tools. Research has also shown that medical errors can result in billion-dollar expenses, including higher medical malpractice lawsuit costs and additional expenses for patients who require therapy to recover from errors in medicine. In addition, The application of predictive analytics can improve patient care and lower the likelihood of disease in the future. Thus, it is anticipated that the growing demand to lower operating costs in the healthcare sector will contribute to the expansion of big data analytics in healthcare market.

Key Restraint Factor for the Big Data Analytics in Healthcare Market

Rising Concerns About Safety Could Prevent Market Expansion:

The technology creates serious questions about data security and privacy, as well as about issues like fake data creation, the need for real-time protection, and its desire. Some of the current areas that require attention are the remote warehouse, improper identity management, inadequate acquisitions in the information security and systems, human error, networked appliances, and Internet of Things applications. Attempting to get around these problems is extremely difficult for associations. It is anticipated that the growing frequency of data loss incidents and cyberattacks on businesses that store customer data would hinder the industry's ability to grow. Furthermore, it is anticipated that upholding data privacy regulations such as the EU General...

In 2023, there were more than *** incidents of data compromises in the healthcare sector in the United States. Reaching its all-time highest. This indicates a significant growth since 2005 when the industry saw only ** cases of data compromises in the country.

In 2023, the most significant healthcare data breach incident in the United States was the HCA Healthcare breach. The Nashville-based company is the largest health system in the United States. During the July 2023 breach, more than *** U.S. hospitals and ***** healthcare sites reported about unauthorized access. The incident impacted ***** million individuals in the United States. Second-ranked PJ&A data breach impacted nearly **** million individuals.

The big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% till 2035

The global big data in healthcare market was estimated to be worth $14.25 billion in 2017 & is expected to grow over $68.75 billion by 2025. BIS Research report on Big Data in Healthcare Market offer detailed industry analysis including market report, size, growth, share, trends, value & forecast.

Success.ai’s Healthcare Industry Leads Data for the North American Healthcare Sector provides businesses with a comprehensive dataset designed to connect with healthcare organizations, decision-makers, and key stakeholders across the United States, Canada, and Mexico. Covering hospitals, pharmaceutical firms, biotechnology companies, and medical equipment providers, this dataset delivers verified contact information, firmographic details, and actionable business insights.

With access to over 170 million verified professional profiles and 30 million company profiles, Success.ai ensures your outreach, market research, and strategic initiatives are powered by accurate, continuously updated, and AI-validated data. Backed by our Best Price Guarantee, this solution is your key to success in the North American healthcare market.

Why Choose Success.ai’s Healthcare Industry Leads Data?

1. Verified Contact Data for Precision Targeting

   • Access verified work emails, phone numbers, and LinkedIn profiles of healthcare executives, clinical managers, procurement officers, and compliance leaders.
   • AI-driven validation ensures 99% accuracy, reducing bounce rates and improving engagement efficiency.

2. Comprehensive Coverage of North America’s Healthcare Sector

   • Includes profiles of organizations such as hospitals, private clinics, research facilities, biotech firms, and medical supply distributors.
   • Gain visibility into the unique healthcare dynamics of the United States, Canada, and Mexico, including regional trends, regulatory differences, and market opportunities.

3. Continuously Updated Datasets

   • Real-time updates reflect changes in leadership, organizational structures, service offerings, and market activities.
   • Ensure your outreach and strategy stay relevant and aligned with the rapidly evolving healthcare industry.

4. Ethical and Compliant

   • Adheres to GDPR, CCPA, and other global privacy regulations, ensuring responsible and compliant use of data for your campaigns.

Data Highlights:

• 170M+ Verified Professional Profiles: Engage with decision-makers and influencers across North America’s healthcare sector.
• 30M Company Profiles: Access detailed firmographic data, including organization sizes, revenue ranges, and geographic footprints.
• Decision-Maker Contacts: Connect with CEOs, CMOs, clinical directors, R&D leaders, and procurement managers shaping healthcare strategies.
• Operational Insights: Understand supply chains, service lines, and product pipelines within the healthcare ecosystem.

Key Features of the Dataset:

1. Healthcare Decision-Maker Profiles

   • Identify and connect with healthcare leaders driving innovation, procurement decisions, and patient care delivery.
   • Engage with professionals responsible for technology adoption, regulatory compliance, and resource management.

2. Advanced Filters for Precision Targeting

   • Filter companies by sector (hospitals, biotech, pharma, medical devices), geographic location, revenue size, or workforce composition.
   • Tailor your outreach to align with the unique needs and priorities of North American healthcare organizations.

3. Market and Operational Insights

   • Analyze trends such as telemedicine adoption, value-based care initiatives, and investments in AI and automation.
   • Leverage these insights to position your solutions effectively within a rapidly transforming industry.

4. AI-Driven Enrichment

   • Profiles enriched with actionable data allow for personalized messaging, highlight your value propositions, and improve engagement outcomes with healthcare stakeholders.

Strategic Use Cases:

1. Sales and Lead Generation

   • Offer technology solutions, medical devices, or consulting services to healthcare organizations seeking operational improvements.
   • Build relationships with procurement managers, clinical directors, and decision-makers responsible for resource allocation.

2. Marketing and Demand Generation

   • Target marketing teams and outreach coordinators within healthcare organizations to promote software solutions, diagnostic tools, or patient engagement platforms.
   • Leverage verified contact data to launch impactful email and multi-channel marketing campaigns.

3. Regulatory Compliance and Risk Mitigation

   • Connect with compliance officers and legal teams responsible for adhering to healthcare regulations and standards.
   • Present solutions for streamlined reporting, risk management, and quality assurance processes.

4. Recruitment and Workforce Optimization

   • Engage HR professionals and hiring managers in recruiting healthcare talent, from clinical staff to administrative roles.
   • Provide staffing solutions, training platforms, or workforce management tools tailored to healthcare environments.

Why Choose Success.ai?

1. Best Price Guarantee
   • Access premium-q...

After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.

The following dataset provides state-aggregated data for hospital utilization. These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities.

The file will be updated regularly and provides the latest values reported by each facility within the last four days for all time. This allows for a more comprehensive picture of the hospital utilization within a state by ensuring a hospital is represented, even if they miss a single day of reporting.

No statistical analysis is applied to account for non-response and/or to account for missing data.

The below table displays one value for each field (i.e., column). Sometimes, reports for a given facility will be provided to more than one reporting source: HHS TeleTracking, NHSN, and HHS Protect. When this occurs, to ensure that there are not duplicate reports, prioritization is applied to the numbers for each facility.

On June 26, 2023 the field "reporting_cutoff_start" was replaced by the field "date".

On April 27, 2022 the following pediatric fields were added: